Ubs Group Ag Axogen, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Axogen, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 19,108 shares of AXGN stock, worth $280,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,108

Previous 12,865 48.53%

Holding current value

$280,887

Previous $93,000 187.1%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $46,947 - $91,709	6,243 Added 48.53%	19,108 $267,000
Q2 2024 Aug 13, 2024	SELL	$5.67 - $8.06 $164,951 - $234,481	-29,092 Reduced 69.34%	12,865 $93,000
Q1 2024 May 13, 2024	SELL	$6.63 - $10.69 $18,152 - $29,269	-2,738 Reduced 6.13%	41,957 $338,000
Q4 2023 Feb 09, 2024	BUY	$3.61 - $7.76 $72,286 - $155,386	20,024 Added 81.16%	44,695 $305,000
Q3 2023 Nov 09, 2023	SELL	$4.68 - $9.26 $68,978 - $136,483	-14,739 Reduced 37.4%	24,671 $123,000
Q2 2023 Aug 11, 2023	BUY	$8.5 - $10.38 $82,161 - $100,333	9,666 Added 32.5%	39,410 $359,000
Q1 2023 May 12, 2023	BUY	$7.53 - $10.95 $29,502 - $42,902	3,918 Added 15.17%	29,744 $281,000
Q4 2022 Feb 08, 2023	BUY	$9.44 - $13.09 $78,569 - $108,948	8,323 Added 47.55%	25,826 $257,000
Q3 2022 Nov 10, 2022	SELL	$8.14 - $12.25 $3,679 - $5,537	-452 Reduced 2.52%	17,503 $209,000
Q2 2022 Aug 10, 2022	SELL	$6.99 - $10.0 $18,446 - $26,390	-2,639 Reduced 12.81%	17,955 $147,000
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $114,076 - $168,129	-15,713 Reduced 43.28%	20,594 $163,000
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $178,393 - $324,352	20,272 Added 126.42%	36,307 $341,000
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $20,255 - $28,887	-1,330 Reduced 7.66%	16,035 $253,000
Q2 2021 Aug 13, 2021	SELL	$17.8 - $23.5 $214,810 - $283,598	-12,068 Reduced 41.0%	17,365 $375,000
Q1 2021 May 12, 2021	BUY	$17.18 - $22.6 $106,516 - $140,120	6,200 Added 26.69%	29,433 $596,000
Q4 2020 Feb 11, 2021	BUY	$11.5 - $17.96 $89,746 - $140,159	7,804 Added 50.58%	23,233 $416,000
Q3 2020 Nov 12, 2020	SELL	$10.62 - $13.12 $134,810 - $166,545	-12,694 Reduced 45.14%	15,429 $179,000
Q2 2020 Jul 31, 2020	SELL	$7.35 - $10.81 $51,824 - $76,221	-7,051 Reduced 20.05%	28,123 $260,000
Q1 2020 May 01, 2020	BUY	$8.38 - $17.34 $154,585 - $319,870	18,447 Added 110.28%	35,174 $366,000
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $20,291 - $33,759	1,815 Added 12.17%	16,727 $299,000
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $37,333 - $63,180	-3,088 Reduced 17.16%	14,912 $186,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $34,225 - $47,119	1,850 Added 11.46%	18,000 $356,000
Q1 2019 May 14, 2019	BUY	$14.62 - $22.13 $55,629 - $84,204	3,805 Added 30.82%	16,150 $340,000
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $286,445 - $641,108	-16,761 Reduced 57.59%	12,345 $252,000
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $6,265 - $10,285	184 Added 0.64%	29,106 $1.07 Million
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $91,314 - $132,615	2,526 Added 9.57%	28,922 $1.45 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $196,078 - $323,449	8,036 Added 43.77%	26,396 $964,000
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $57,072 - $88,231	3,085 Added 20.2%	18,360 $520,000
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $27,820 - $36,745	1,899 Added 14.2%	15,275 $295,000
Q2 2017 Aug 14, 2017	SELL	N/A	-2,765 Reduced 17.13%	13,376 $224,000
Q1 2017 Nov 14, 2017	BUY	N/A	16,141	16,141 $169,000

Others Institutions Holding AXGN

# of Institutions

163

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $622M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account